<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Checkpoint Trends Limited (formerly known as Rubra Medicaments Limited, Scrip Code: 531099) has filed an initial disclosure with BSE dated April 22, 2025, as required under SEBI's circulars on Large Corporates. The company has confirmed that it does NOT qualify as a 'Large Corporate' as per the applicability criteria specified under the SEBI circulars dated November 26, 2018, and October 19, 2023. The company's outstanding borrowings as of March 31, 2025, are reported as 'Not Applicable,' and no credit rating has been obtained. The filing was signed by Pradeep Kumar, Whole-time Director. BSE Limited has been named as the stock exchange where any shortfall-related fine would be paid, though this is not applicable in this case.
This is a routine annual compliance filing with no material impact on shareholders or the stock price. The company essentially confirms it falls below the Large Corporate threshold (typically ₹100 crore+ in outstanding borrowings) and is exempt from SEBI's mandatory incremental borrowing requirements for Large Corporates.